thanks GA . . . it's blatantly obvious that reese has no plans to reverse merge into a shell, or he would have disclosed the plan . . . this does CONFIRM THE RECENT FORM D FILING claiming NO to a planned merger anytime soon . . .
we can officially call 2015 done, maybe something will change in 2016 . . .
dc and JIm..We are getting closer to the planned reverse merger between Provista Diagnostics and Radient Shell according to the 2010 LOI..Look for Uni-Pharma partnership to promote PDX Cancer tests worldwide.....
The monies will be utilized for key management hires. Who Can It Be Now? Not the Aussies you understand.. E.F. Wolf
From August 4,2015 offering key management hires
From March 17,2015 offering..
key clinical hires
August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0 Million of Series A-2 Preferred financing. All of the funds come from existing investors exercising warrants from a previous financing round. The proceeds will be used for continued commercial development, prospective clinical trials, key management hires and general corporate purposes.
NEW YORK, NY – March 17, 2015: Provista Diagnostics, Inc., a privately-held molecular diagnostics company headquartered in New York, today announced the closing of $3.9 Million of Series A-1 Preferred financing. All of the funds come from existing investors exercising warrants from a previous financing round. The proceeds will be used for continued commercial development, prospective clinical trials, key clinical hires and general corporate purposes.